TriLink BioTechnologies, LLC (TriLink) is an industry leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA. TriLink is certified ISO 9001:2015, operates a robust and ICH Q7 Section 19 compliant quality system, and practices continual improvement of its quality standards. TriLink's product management, manufacturing and quality assurance teams work together to understand the challenges of each synthesis and develop and document required processes and materials.
TriLink specializes in the synthesis and production of complex and highly-modified nucleic acids for research, diagnostics, pre-clinical therapeutic and pharmaceutical applications. The scientists and technicians at Trilink have more than 20 years of experience designing, developing, and manufacturing custom oligonucleotides, mRNA transcripts, nucleotides, PCR & RT-PCR, NGS library preparation kits, bioconjugation, custom chemistry and other small molecules.
All TriLink products undergo final analytical testing, to ensure the product meets our release specifications. The QC analyses are then incorporated in the certificate of analysis provided with each product. Every TriLink product and related documentation is reviewed by Quality Assurance and verified to be correct before shipment.
Therapeutic cGMP manufacturing available.